Camlin Fine Sciences Ratios

Camlin Fine Sciences Ltd Ratios

The Camlin Fine Sciences Ltd Ratios page provides a complete fundamental analysis of Camlin Fine Sciences Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Camlin Fine Sciences Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Camlin Fine Sciences Ltd (NSE: CAMLINFINE, BSE: 532834) is currently trading at ₹96.93, with a market capitalization of ₹18.62B. As a major player in the Process industries sector and Chemicals: specialty industry, Camlin Fine Sciences Ltd remains a key stock for fundamental analysis using Camlin Fine Sciences Ltd Ratios.

Camlin Fine Sciences Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Camlin Fine Sciences Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Camlin Fine Sciences Ltd Ratios.

Historically, the Camlin Fine Sciences Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 41.42
• 2021: 30.62
• 2020: 37.95

The decline in Camlin Fine Sciences Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Camlin Fine Sciences Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 3.50.

Historical P/B trend:

• 2024: 3.50
• 2023: 1.73
• 2022: 2.44
• 2021: 2.93

Camlin Fine Sciences Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Camlin Fine Sciences Ltd P/S ratio currently stands at 1.75, an important part of Camlin Fine Sciences Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.75
• 2023: 1.04
• 2022: 1.28
• 2021: 1.32

The rising Camlin Fine Sciences Ltd P/S ratio indicates improved revenue valuation by investors.

Camlin Fine Sciences Ltd Price to Cash Flow Ratio (P/CF)

The Camlin Fine Sciences Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Camlin Fine Sciences Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 22.37
• 2022: 0
• 2021: 15.26
• 2020: 27.45

The declining Camlin Fine Sciences Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Camlin Fine Sciences Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Camlin Fine Sciences Ltd EV currently stands at ₹33.7B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 33.7B
• 2023: 20.9B
• 2022: 28.64B
• 2021: 23.78B

Camlin Fine Sciences Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Camlin Fine Sciences Ltd EV/EBITDA ratio is currently 15.81, a key metric in Camlin Fine Sciences Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 15.81
• 2023: 11.07
• 2022: 13.11
• 2021: 15.30

Higher Camlin Fine Sciences Ltd EV/EBITDA suggests premium valuation.

Camlin Fine Sciences Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Camlin Fine Sciences Ltd D/E ratio is currently 0.76, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.76
• 2023: 0.79
• 2022: 0.98
• 2021: 0.86

Camlin Fine Sciences Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Camlin Fine Sciences Ltd ROE currently stands at 7.75%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 7.75
• 2023: 7.73
• 2022: 6.65
• 2021: 8.72

Declining ROE indicates pressure on profitability.

Camlin Fine Sciences Ltd Ratios Analysis Summary

The Camlin Fine Sciences Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Camlin Fine Sciences Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Camlin Fine Sciences Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.